-
Mashup Score: 2ASH Research Collaborative and Reagan-Udall Foundation for the FDA Launch Sickle Cell Disease Real-World Data Project | Reagan-Udall Foundation - 24 day(s) ago
(WASHINGTON, April 17, 2024) –The ASH Research Collaborative (ASH RC) and the Reagan-Udall Foundation for the Food and Drug Administration (FDA Foundation) are launching the Real-World Evidence Consortium for Sickle Cell Disease (SCD) to develop consensus recommendations on clinical outcomes important to treating people with SCD and apply those standards to real-world data sets. The goal of the Consortium is to improve the lives of individuals living with SCD through real-world evidence generation and cutting-edge research.
Source: reaganudall.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Advancing Psychedelic Clinical Study DesignVirtual Public Meeting Day 1: January 31, 2024 | 10am-2pm (eastern) Day 2: February 1, 2024 | 10am-1pm (eastern) Join the Foundation as we host “Advancing Psychedelic Clinical Study Design,” a two-day virtual public meeting that will explore empiric approaches to address key issues in psychedelic drug development and research.
Source: reaganudall.orgCategories: General Medicine News, General HCPsTweet-
Lastly, on January 31 and February 1, the Reagan-Udall Foundation for the FDA, will hold a virtual public workshop, “Advancing Psychedelic Clinical Study Design.” https://t.co/CJdP6l9S3L
-
-
Mashup Score: 5Integrating Clinical Studies Into Health Care Delivery: Post-Market Evidence Generation for Medical Products | Reagan-Udall Foundation - 6 month(s) ago
Integrating Clinical Studies Into Health Care Delivery: Post-Market Evidence Generation for Medical ProductsVirtual Public Meeting
Source: reaganudall.orgCategories: General Medicine News, CardiologistsTweet-
Interested in simpler evidence generation and clinical trials? Join this meeting: Integrating Clinical Studies Into Health Care Delivery: Post-Market Evidence Generation for Medical Products | Reagan-Udall Foundation https://t.co/U17RZUuO9C
-
-
Mashup Score: 0Expert Panel Completes Operational Evaluation of FDA’s Human Foods Program | Reagan-Udall Foundation - 1 year(s) ago
(December 6, 2022) Today, the Independent Expert Panel for Foods submitted its Operational Evaluation of FDA’s Human Foods Program to Dr. Robert Califf, Commissioner for Food and Drugs. The evaluation and report were facilitated by the Reagan-Udall Foundation at Dr. Califf’s request.
Source: reaganudall.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Operational Evaluation of the @US_FDA human foods program by @reaganudall https://t.co/vEVezNGHcM ... 1/n https://t.co/DIKBpNVBIs
-
-
Mashup Score: 0
The tobacco operational evaluation began September 21, 2022. The evaluation will address the Center for Tobacco Products’ programs for regulations and guidance, application review, compliance and enforcement, and communication with the public and other stakeholders. The panel will not address tobacco policy issues, which are outside the scope of this evaluation. The report is due to Commissioner…
Source: reaganudall.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
3/n ... Operational Evaluation of @US_FDA ’s Tobacco Program by @reaganudall https://t.co/XIFjaW5C3U The tobacco operational evaluation began September 21, 2022 & is due to present report to @FDACommissioner on December 19, 2022.
-
-
Mashup Score: 5
(August 17, 2022) The Reagan-Udall Foundation announced today that former Commissioner of Food and Drugs Jane E. Henney, MD, and former FDA Chief of Staff Lauren Silvis, JD, will lead the operational evaluation of the Food and Drug Administration’s human foods and tobacco work. Henney will lead the evaluation team focused on human foods while Silvis will lead the team focused on tobacco. The…
Source: reaganudall.orgCategories: Healthcare Professionals, Latest HeadlinesTweet-
At FDA @LaurenRSilvis helped lead strategy around many critical initiatives, including enforcement efforts, and was thoughtful in applying the FDA's statutory authorities dynamically, in pursuit of public health goals. She'll bring the same to this effort https://t.co/8LwkNvUR0U
-
-
Mashup Score: 26About Us | Reagan-Udall Foundation - 2 year(s) ago
The Reagan-Udall Foundation for the Food and Drug Administration is an independent 501(c)(3) organization created by Congress “to advance the mission of the FDA to modernize medical, veterinary, food, food ingredient, and cosmetic product development, accelerate innovation, and enhance product safety.”
Source: reaganudall.orgCategories: HIV/AIDS, Latest HeadlinesTweet-
I'm pleased to be new member of the board of Reagan-Udall Foundation for the FDA. I am looking forward to helping advance mission of FDA to modernize drug development, improve drug safety and accelerate innovation. https://t.co/u1JJH7yUpC
-
-
Mashup Score: 0Reagan-Udall Foundation for the FDA Announces Two New Board Members | Reagan-Udall Foundation - 3 year(s) ago
(June 3, 2021) The Reagan-Udall Foundation for the Food and Drug Administration (FDA Foundation) is expanding its leadership with the addition of two new Board members: Christie Boutte, PharmD, RPh, Senior Vice President of Reimbursement, Innovation, and Advocacy for the National Association of Chain Drug Stores (NACDS) and Phil Febbo, MD, Chief Medical Officer for Illumina.
Source: reaganudall.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
So excited to have them join us on the Board! Reagan-Udall Foundation for the FDA Announces Two New Board Members https://t.co/qmZt6oWnMe
-
-
Mashup Score: 22021 Annual Public Meeting | Reagan-Udall Foundation - 3 year(s) ago
Each year, the Reagan-Udall Foundation for the FDA conducts an Annual Public Meeting of its Board of Directors to share its activities in support of the U.S. Food and Drug Administration. This free virtual meeting is open to the public, but advanced registration is required.
Source: reaganudall.orgCategories: Latest Headlines, Rare DiseaseTweet-
https://t.co/jXi81AtncJ
-
-
Mashup Score: 12021 Annual Public Meeting | Reagan-Udall Foundation - 3 year(s) ago
Stakeholder engagement, innovation, and the use of real-world evidence are key components in improving America’s public health. Join us for an in-depth conversation on FDA priorities with Acting Commissioner Dr. Janet Woodcock followed by an overview of the FDA Foundation’s programs, partnerships, and impact. This free virtual meeting is open to the public, but advanced registration is required.
Source: reaganudall.orgCategories: Latest Headlines, Rare DiseaseTweet-
RT @reaganudall: Register today! https://t.co/ZRm1XHwSfJ https://t.co/a9JYvAdb8M
-
Eager to begin this exciting new collaboration! ASH Research Collaborative and Reagan-Udall Foundation for the FDA Launch Sickle Cell Disease Real-World Data Project https://t.co/brbnEHl3tu